Cargando…
Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
Metformin is the most widely prescribed drug to treat patients with type II diabetes, for whom retrospective studies suggest that metformin may have anticancer properties. However, in experiments performed with isolated cells, authors have reported both pro- and anti-apoptotic effects of metformin....
Autor principal: | Fontaine, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304344/ https://www.ncbi.nlm.nih.gov/pubmed/30619086 http://dx.doi.org/10.3389/fendo.2018.00753 |
Ejemplares similares
-
Metformin Inhibits Mitochondrial Complex I To Promote Health
por: Chandel, Navdeep
Publicado: (2021) -
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
por: Wheaton, William W, et al.
Publicado: (2014) -
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
por: Ling, Sunbin, et al.
Publicado: (2017) -
Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023) -
Individualization of FSH Doses in Assisted Reproduction: Facts and Fiction
por: Broekmans, Frank J.
Publicado: (2019)